Lung Cancer, Nonsmall Cell Clinical Trials
0 recruiting
Showing 1–11 of 11 trials
Recruiting
Prospective Data Collection Initiative on Thoracic Malignancies
Lung CancerThoracic CancerThymus Cancer+5 more
Dutch Society of Physicians for Pulmonology and Tuberculosis12,000 enrolled10 locationsNCT06996249
Recruiting
Phase 1Phase 2
Tocilizumab and Atezolizumab in Adults With Locally Advanced or Metastatic Non-Small Cell Lung Cancer Refractory to 1st Line Immune Checkpoint Inhibitor-Based Therapy
Lung Cancer, Nonsmall Cell
Abramson Cancer Center at Penn Medicine28 enrolled1 locationNCT04691817
Recruiting
Not Applicable
Immunonutrition for Improving the Efficacy of Immunotherapy in Patients With Metastatic Non-small Cell Lung Cancer
Lung Cancer, Nonsmall Cell
Fondazione IRCCS Policlinico San Matteo di Pavia180 enrolled1 locationNCT05384873
Recruiting
A Multicenter Cancer Biospecimen Collection Study
Cancer of Head and NeckLung Cancer, Nonsmall Cell
Cofactor Genomics, Inc.1,650 enrolled1 locationNCT04510129
Recruiting
Phase 2
ctDNA-MRD Guided Consolidation Toripalimab in Stage IB-IIIA NSCLC
Lung Cancer, Nonsmall Cell
Sun Yat-sen University80 enrolled1 locationNCT06426511
Recruiting
Phase 2
Efficacy Analysis of Neoadjuvant Treatment in Lung Cancer Using Low-dose Nivolumab Combined With Chemotherapy
Lung Cancer, Nonsmall Cell
Aline Fusco Fares, MD33 enrolled1 locationNCT06667154
Recruiting
Not Applicable
Study of PRO in Patients with Advanced Pancreatic or Biliary Tract Cancer (BetterEveryDay)
Pancreatic CancerLung Cancer, Nonsmall Cell
Inna Chen, MD274 enrolled1 locationNCT04611867
Recruiting
Therapeutic ResistAnce and Clonal Evolution Assessed With Liquid Biopsy in ICIs Treated NSCLC Patients
Lung NeoplasmsLung Cancer, Nonsmall CellAdenocarcinoma of Lung+1 more
Geneplus-Beijing Co. Ltd.250 enrolled1 locationNCT04566432
Recruiting
Not Applicable
Understanding and Overcoming the Early Adaptive Resistance to EGFR Tyrosine-kinase Inhibitors in Lung Cancer Patients
Lung Cancer, Nonsmall Cell
University Hospital, Toulouse80 enrolled1 locationNCT04222335
Recruiting
Phase 3
A Randomised Open-label Phase III Trial of REduced Frequency Pembrolizumab immuNothErapy for First-line Treatment of Patients With Advanced Non-small Cell Lung Cancer (NSCLC)
Lung Cancer, Nonsmall Cell
Imperial College London1,750 enrolled37 locationsNCT05085028
Recruiting
Phase 1Phase 2
A Phase I/II Clinical Study of SAF-189s in Non-small Cell Lung Cancer (NSCLC) Patients
Advanced Solid TumorAdvanced CancerLung Cancer, Nonsmall Cell
Shanghai Fosun Pharmaceutical Industrial Development Co. Ltd.280 enrolled41 locationsNCT04237805